Changes of plasma D-Dimer and fibrinogen in patients with lacunar cerebral infarction after treatment with batroxobin:A comparative analysis
Wang Fen-die
Abstract
Wang Fen-die
Abstract
Objective:To observe the changes of plasma D-Dimer and fibrinogen(FIB)in patients with lacunar cerebral infarction(LI)after treatment with Batroxobin.Methods:A total of 120 patients with LI were randomly divided into Batroxobin treatment group(n=60)and control group(n=60)and treated with neurophic and normal drugs.Batroxobin was used in Batroxobin treatment group on days 1,3,5,and 7.Thirty patients with acute cerebral infarction served as treatment group,30 persons served as control group.Levels of D-Dimer and FIB were measured in 120 patients before and after treatment.Results:Before treatment,the levels of D-Dimer were lower in patients with LI than in patients with acute cerebral infarction(P0.05)and there was no significant difference between patients with LI and controls(P0.05).The D-Dimer level was higher and FIB level was lower 7 days after treatment with Batroxobin than before treatment with Batroxobin(P0.05).The D-Dimer level was similar 14 days after treatment with Batroxobin to that before treatment with Batroxobin(P0.05).Conclusion:Batroxobin increases fibrinolytic activity,reduces coagulation activity,and accelerates thrombolysis in patients with LI.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the changes of plasma D-Dimer and fibrinogen(FIB)in patients with lacunar cerebral infarction(LI)after treatment with Batroxobin.Methods:A total of 120 patients with LI were randomly divided into Batroxobin treatment group(n=60)and control group(n=60)and treated with neurophic and normal drugs.Batroxobin was used in Batroxobin treatment group on days 1,3,5,and 7.Thirty patients with acute cerebral infarction served as treatment group,30 persons served as control group.Levels of D-Dimer and FIB were measured in 120 patients before and after treatment.Results:Before treatment,the levels of D-Dimer were lower in patients with LI than in patients with acute cerebral infarction(P0.05)and there was no significant difference between patients with LI and controls(P0.05).The D-Dimer level was higher and FIB level was lower 7 days after treatment with Batroxobin than before treatment with Batroxobin(P0.05).The D-Dimer level was similar 14 days after treatment with Batroxobin to that before treatment with Batroxobin(P0.05).Conclusion:Batroxobin increases fibrinolytic activity,reduces coagulation activity,and accelerates thrombolysis in patients with LI.
Key concepts: Batroxobin, Fibrinogen, Medicine, D-dimer, Internal medicine, Cerebral infarction, Gastroenterology, Thrombolysis